Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13.1M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
+559K
-
Total reported value, excl. options
-
$625M
-
Value change
-
-$9.31M
-
Put/Call ratio
-
0.74
-
Number of buys
-
59
-
Number of sells
-
-66
-
Price
-
$40.50
Significant Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q1 2016
163 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q1 2016.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
.
Largest 10 shareholders include ProQuest Associates IV LLC (4.78M shares), Park West Asset Management LLC (1.47M shares), JANUS CAPITAL MANAGEMENT LLC (1.45M shares), JW Asset Management, LLC (760K shares), Consonance Capital Management LP (694K shares), STATE STREET CORP (629K shares), Cormorant Asset Management, LLC (500K shares), BlackRock Fund Advisors (409K shares), Ranger Investment Management, L.P. (404K shares), and VANGUARD GROUP INC (352K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.